参 考 文 献 [1] Yanaba K, Bouaziz JD, Matsushita T, et al. B-lymphocyte contributions to human autoimmune disease. Immunol Rev, 2008, 223:284-299 [2] Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity, 2008, 28(5):639-650. [3] Morris A, M?ller G. Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol, 1968, 101(3):439-445. [4] Wolf SD, Dittel BN, Hardardottir F, et al. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med, 1996, 184(6):2271-2278. [5] Jamin C, Morva A, Lemoine S,et al. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum, 2008,58(7):1900-1906. [6] Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol, 2006, 176(2):705-710. [7] Lenert P, Brummel R, Field EH, et al. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol, 2005, 25(1):29-40. [8] Watanabe R, Fujimoto M, Ishiura N, et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol, 2007, 171(2):560-570. [9] Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol, 2007, 178(12):7868-7878. [10] Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity, 2002, 16(2):219-230. [11] Sun CM, Deriaud E, Leclerc C, et al. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity, 2005, 22(4):467-477. [12] Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev, 2008, 224:201-214. [13] Booth JS, Griebel PJ, Babiuk LA, et al. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol, 2009, 2(3):265-275. [14] Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol, 2009, 182(6):3492–3502. [15] Yin Z, Bahtiyar G, Zhang N, et al. IL-10 regulates murine lupus. J Immunol, 2002, 169(4):2148-2155. [16] Yanaba K, Hamaguchi Y, Venturi GM, et al. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol, 2007, 179(2):1369-1380. [17] Korganow AS, Ji H, Mangialaio S, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity,1999,10(4):451-461. [18] Lenert P, Goeken A, Handwerger BS, et al. Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides. J Clin Immunol, 2003, 23(3):202-213. [19] Tian J, Zekzer D, Hanssen L, et al. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol, 2001, 167(2):1081-1089. [20] Mann MK, Maresz K, Shriver LP, et al. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol, 2007, 178(6):3447-3456. [21] Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol,2000,12(5):597-605. [22] D'Orazio TJ, Mayhew E, Niederkorn JY.Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol, 2001,166(1):26-32. [23] Yan, J, M.J.Mamula. B and T cell tolerance and autoimmunity in autoantibody transgenic mice. Int Immunol, 2002, 14(8): 963–971. [24] Lemoine S, Morva A, Youinou P, et al. Regulatory B cells in autoimmune diseases: how do they work? Ann N Y Acad Sci, 2009, 1173:260-267. [25] Amel Kashipaz MR, Huggins ML, Lanyon P, et al. Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells. Lupus, 2003, 12(5):356-363. [26] Díaz-Alderete A, Crispin JC, Vargas-Rojas MI, et al. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. J Autoimmun, 2004, 23(4):379-383. [27] Ring S, Oliver SJ, Cronstein BN, et al. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J Allergy Clin Immunol, 2009, 123(6):1287-1296. [28] Maeda A, Schwarz A, Bullinger A, et al. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol, 2008, 181(9):5956-5962. [29] Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med, 1997, 186(10):1749-1756. [30] Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol, 2007, 179(11):7225-7232. [31] Mauri C, Gray D, Mushtaq N, et al. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med, 2003, 197(4):489-501. [32] Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol, 2002, 3(10):944-950. [33] Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest, 2008, 118(10):3420-3430. [34] Noechel B, Lohr J, Kahn E, et al. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol, 2005, 175(1):21–26. [35] Serra P, Santamaria P. To 'B' regulated: B cells as members of the regulatory workforce. Trends Immunol, 2006, 27(1):7-10. [36] Khazaie K, von Boehmer H. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol, 2006, 16(2):124-136. [37] Inoue S, Leitner WW, Golding B, et al. Inhibitory effects of B cells on antitumor immunity. Cancer Res, 2006, 66(15):7741-7747. [38] Kim S, Fridlender ZG, Dunn R, et al. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. J Immunother, 2008, 31(5):446-457. [39] Gillan V, Lawrence RA, Devaney E. B cells play a regulatory role in mice infected with the L3 of Brugia pahangi. Int Immunol, 2005, 17(4):373-382. [40] Majlessi L, Lo-Man R, Leclerc C. Regulatory B and T cells in infections. Microbes Infect, 2008, 10(9):1030-1035. [41] Rowe V, Banovic T, MacDonald KP, et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood, 2006, 108(7):2485-2492.